Lin Xiumin, Tan Shutao, Fu Lin, Dong Qianze
Department of Pathology, College of Basic Medical Science, China Medical University, Shenyang, People's Republic of China.
Department of Pathology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Onco Targets Ther. 2020 Apr 29;13:3583-3594. doi: 10.2147/OTT.S237306. eCollection 2020.
Dysregulation of BCAT1 has been implicated in carcinogenesis. However, its clinical significance and biological roles in human non-small cell lung cancer (NSCLC) are not clear.
Immunohistochemistry was used to examine the protein expression of BCAT1 in 107 cases of lung cancer tissues. Biological roles and potential mechanisms of BCAT1 were examined using MTT, colony formation assay, Matrigel invasion assay, Western blot, RNA-sequencing, and luciferase reporter assay.
We found BCAT1 was upregulated in 60 of 107 lung cancer tissues and correlated with nodal metastasis, advanced stages and short overall survival. The Cancer Genome Atlas (TCGA) and ONCOMINE data analyses also indicated that BCAT1 was elevated in human NSCLC tissues. BCAT1 protein was higher in lung cancer cell lines than in normal bronchial epithelial cell line. BCAT1 overexpression increased the cell growth rate, colony numbers and invasion abilities in both BEAS-2B and H1299 cell lines, while BCAT1 siRNA decreased the cell proliferation rate, colony numbers, and inhibited invasion. RNA-sequencing (RNA-seq) and Gene Set Enrichment Analysis (GSEA) analyses indicated that BCAT1 overexpression activated Wnt/Myc signaling. Western blot revealed that BCAT1 increased protein expression of MMP7, cyclin D1, c-Myc, and decreased E-cadherin and p27 in the BEAS-2B and H1299 cell lines. Further experiments showed that BCAT1 overexpression elevated Wnt reporter luciferase activity and increased activate β-catenin protein while downregulating p-β-catenin protein expression. BCAT1 knockdown showed the opposite effects. TCGA data analysis suggested positive correlations between BCAT1 and c-Myc, cyclin D1, and MMP7 mRNA. Blockage of Wnt signaling using an inhibitor (ICG-001) downregulated c-Myc, cyclin D1, MMP7 expressions and abolished the upregulating effects of BCAT1 on these proteins.
In summary, our data showed that BCAT1 was overexpressed in human NSCLCs. BCAT1 facilitated cell proliferation and invasion possibly through regulation of the Wnt signaling pathway.
BCAT1失调与肿瘤发生有关。然而,其在人类非小细胞肺癌(NSCLC)中的临床意义和生物学作用尚不清楚。
采用免疫组织化学法检测107例肺癌组织中BCAT1的蛋白表达。通过MTT法、集落形成试验、基质胶侵袭试验、蛋白质印迹法、RNA测序和荧光素酶报告基因试验检测BCAT1的生物学作用和潜在机制。
我们发现107例肺癌组织中有60例BCAT1表达上调,且与淋巴结转移、晚期阶段及总生存期短相关。癌症基因组图谱(TCGA)和ONCOMINE数据分析也表明,BCAT1在人类NSCLC组织中升高。肺癌细胞系中BCAT1蛋白水平高于正常支气管上皮细胞系。BCAT1过表达增加了BEAS-2B和H1299细胞系的细胞生长速率、集落数量和侵袭能力,而BCAT1小干扰RNA降低了细胞增殖速率、集落数量并抑制了侵袭。RNA测序(RNA-seq)和基因集富集分析(GSEA)分析表明,BCAT1过表达激活了Wnt/Myc信号通路。蛋白质印迹显示,在BEAS-2B和H1299细胞系中,BCAT1增加了MMP7、细胞周期蛋白D1、c-Myc的蛋白表达,降低了E-钙黏蛋白和p27的表达。进一步实验表明,BCAT1过表达提高了Wnt报告基因荧光素酶活性,增加了激活型β-连环蛋白的蛋白表达,同时下调了磷酸化β-连环蛋白的蛋白表达。BCAT1敲低显示出相反的效果。TCGA数据分析表明BCAT1与c-Myc、细胞周期蛋白D1和MMP7 mRNA之间呈正相关。使用抑制剂(ICG-001)阻断Wnt信号通路可下调c-Myc、细胞周期蛋白D1、MMP7的表达,并消除BCAT1对这些蛋白的上调作用。
总之,我们的数据表明BCAT1在人类NSCLC中过表达。BCAT1可能通过调节Wnt信号通路促进细胞增殖和侵袭。